Nearly 70% of children with low-risk peanut allergy tolerated a peanut oral food challenge, negating the need for allergy treatment, data from one center showed. Researchers sought to determine how ...

Peanut oral immunotherapy safe for young children aged 1 to 3 years with slow up-dosing and low maintenance dosing.

Though a large proportion of patients receiving oral immunotherapy (OIT) for food allergy report gastrointestinal (GI) symptoms, a knowledge gap remains for the best approach to determine the ...

Please provide your email address to receive an email when new articles are posted on . Black patients with peanut allergies received oral immunotherapy less frequently than white patients. Patients ...

Thirty-six percent of patients treated with omalizumab were able to tolerate 2000mg of peanut protein and 2 other food allergens without experiencing an allergic reaction compared with 19% of ...

A recent study attempted to determine the prevalence of eosinophilic esophagitis (EoE) in a group of patients allergic to milk or egg and undergoing oral immunotherapy (OIT) to those foods, as well as ...

Low-dose oral immunotherapy (OIT) had a favorable safety profile and resulted in fewer severe reactions in preschoolers with single or multiple food allergies. Between May 2019 and October 2022, ...

Please provide your email address to receive an email when new articles are posted on . The days of passive reactive management have passed; it’s time to be proactive. Patients may be able to add ...